Tiziana Life Sciences PLC Share Price London S.E.
Equities
GB00B28XMY25
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- GBX | - |
Sales 2022 | - | Sales 2023 | - | Capitalization | 56.17M 4.43B |
---|---|---|---|---|---|
Net income 2022 | -15M -1.18B | Net income 2023 | -17M -1.34B | EV / Sales 2022 | - |
Net cash position 2022 | 17.76M 1.4B | Net cash position 2023 | 936K 73.75M | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.95
x | P/E ratio 2023 |
-3.29
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 32.56% |
Latest transcript on Tiziana Life Sciences PLC
Managers | Title | Age | Since |
---|---|---|---|
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 10/02/98 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | - |
Vaseem Palejwala
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 30/06/20 |
Willy Simon
BRD | Director/Board Member | 72 | 31/10/15 |
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 10/02/98 |
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |